Navigation Links
FDA Grants Kiadis Pharma Lead Product ATIR Orphan Drug Designation
Date:11/6/2007

AMSTERDAM, The Netherlands, Nov. 6 /PRNewswire/ -- Kiadis Pharma announced today that its lead product ATIR has been granted orphan drug designation by the US Food and Drug Administration (FDA) as a therapy for immune reconstitution and prevention of Graft versus Host Disease (GvHD) following allogeneic bone marrow transplantation. ATIR is currently in phase I/II clinical studies and anticipated to enter clinical phase III studies in 2008.

"This is an important strategic milestone in the development of ATIR as a novel approach which may enable a safe and potentially life-saving mismatched bone marrow transplantation as a treatment option for end-stage blood cancer patients" said Dr. Manja Bouman, Chief Executive Officer of Kiadis Pharma.

The FDA's orphan drug designation is reserved for new therapies being developed to treat diseases or conditions that affect fewer than 200,000 people in the United States. The orphan drug designation provides for an accelerated review process, tax benefits, exemption from user fees and a seven-year period of market exclusivity in the US after product approval.

ATIR is under development to prevent life-threatening GvHD, a major complication of allogeneic bone marrow transplantations. GvHD is a condition caused by the donor immune cells attacking the patient's tissues and organs. Allogeneic bone marrow transplantations today require that the patient and donor immune systems (HLA type) are highly similar in order to reduce the risk of GvHD and therefore rely on matching donors. By preventing the occurrence of GvHD, ATIR enables the use of a mismatched donor and consequently addresses a significant limitation in bone marrow transplantation, the timely availability of a donor.

Every year between 50,000 and 60,000 patients die of blood cancers in the United States alone. For these end-stage and high-risk blood cancer patients bone marrow transplantation is the only treatment option. In addition, a number of
'/>"/>

SOURCE Kiadis Pharma B.V.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
2. Sunesis Pharmaceuticals Reports New Option Grants Under NASDAQ Marketplace Rule 4350
3. American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide
4. USAID Announces First Malaria Communities Program Grants
5. The Highmark Foundation Awards $580,000 in Highmark Healthy High 5 Grants to Four Non-Profit Organizations
6. KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants
7. FDA Grants Clearance to Langford IC Systems, Inc.
8. Dienst Custom Homes Grants Over 40 Wishes in Three Years
9. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
10. PA Health Department Awards Community Primary Care Challenge Grants
11. Kiadis Pharma Announces ATIR Interim Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... 2015 , ... Topical BioMedics, Inc., hosted Amsterdam resident Max ... 10,000 mile journey from Santiago, Chile to Times Square and then Rhinebeck, New ... Americas” project—Max crossed six countries in 168 days on his 39-year-old Moto Guzzi ...
(Date:9/3/2015)... ... September 03, 2015 , ... Real Time Pain Relief ... that professional bull rider David Mason has signed an official endorsement deal with the ... age of six and his first bull at 15. He is an Australian bull ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... the cost of graduated compression garments. However, graduated compression garments are an effective ... care and lymphedema specialist, Robyn Bjork, was recently sponsored by SIGVARIS ...
(Date:9/3/2015)... MO (PRWEB) , ... September 03, 2015 , ... The ... News*, covering the allegations made by IVC filter lawsuits filed against Bard.** ... were harmed when a Bard IVC filter broke or failed, have recently been consolidated ...
(Date:9/3/2015)... (PRWEB) , ... September 03, ... ... Washington, a leading provider of comprehensive eating disorder treatment for adults and ... today that Ileana Calinoiu, MD has joined the medical treatment team. As ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3
... Agreement Would Establish Rules for Union Process, FRESNO, ... delivered a message to CEO Tim Joslin on,Thursday: the ... putting the quality of treatment offered there at risk. ... free and fair election,agreement with employees who are interested ...
... research professionals,from all over the world gathered at the ... Clinical Practice Journal (GCPj) Awards. Opening,this landmark event, Chairman ... said the awards were a most important celebration,of innovation ... hope,it will become a traditional event in the public ...
... Permanente has successfully,certified its greenhouse gas (GHG) emissions ... first health care organization to,earn the distinction of ... voluntarily reporting its 2006 GHG emissions under the,rigorous ... to the organization,s impact on,the environment is another ...
... COLUMBIA, Mo. -- More than 10 million people in the ... are women. For those who could still give birth, cancer ... new $20 million, 5-year program from the National Institutes of ... every aspect of fertility preservation for women with cancer. Part ...
... Pharmaceutical companies,face a unique blend of challenges ... and quality production processes while building,and protecting a ... in the,Multi-Year Compendium of Pharmaceutical Case Studies address ... industry leaders at Global,Benchmarking Council meetings between 2002-2006. ...
... of Military and Veterans Affairs today dedicated a ... and,Sailors, Home., "With the completion of this ... for Pennsylvania,s 1.1 million veterans who,have served so ... Gen.,Jessica L. Wright, state adjutant general. "Now, all ...
Cached Medicine News:Health News:Hospital Workers: Management Threatens Patient Care 2Health News:Good Clinical Practice Journal Awards: Winners Announced 2Health News:Good Clinical Practice Journal Awards: Winners Announced 3Health News:Good Clinical Practice Journal Awards: Winners Announced 4Health News:Kaiser Permanente Achieves Climate Action Leader Status 2Health News:MU researchers to collaborate on $20 million project 2Health News:Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC 2
(Date:9/3/2015)... -- China,s startup business ExtantFuture ... wearable medical device that can continuously monitor the fetal ... guidance for pregnant women. The device will debut on ... measures 4 centimeters in diameter, is as thin as ... an Apple earphone cord. The small and compact device ...
(Date:9/3/2015)... 3, 2015  VirtualScopics, Inc. (NASDAQ: VSCP ... solutions, announced today, they are collaborating with a ... philanthropic, epidemiology study partnering with the Ministry of ... has teamed up with a cardiac sonographer to ... results will be used to identify children with ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/4q3mv2/investigation ) has announced ... Olmesartan Market, 2010-2019" report to their offering. ... by Sankyo Pharmaceuticals Co., Ltd and was patented in ... by FDA to enter the American market in May. ... the world after it succeeded in the US market. ...
Breaking Medicine Technology:Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 2VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 3VirtualScopics, Inc. Collaborates with Large Pharmaceutical Company on a Philanthropic, Epidemiology Study in Africa 4China Olmesartan Investigation Market Report 2010-2019 2
... Bionovo, Inc. (Nasdaq: BNVI, BNVID), a drug discovery and development ... oncology, today announced that Dr. Isaac Cohen, O.M.D., Chairman and ... Healthcare Conference at 4:00 p.m. ET on Tuesday, September 28, ... Palace hotel in New York City. Interested parties ...
... Sept. 21 Anthera Pharmaceuticals, Inc. (Nasdaq: ... definitive agreements with certain accredited investors in connection with ... Section 4(2) of the Securities Act of 1933, as ... of the transaction, Anthera will receive gross proceeds of ...
Cached Medicine Technology:Bionovo to Present at the JMP Securities Healthcare Conference 2Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 2Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 3Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing 4
... concave seats and large backrests with lumbar ... armrests, and casters and glides. • Choose ... a variety of environments including: industry, education, ... and office. • With tubular base • ...
... chairs with concave seats and large backrests ... seats, backrests, armrests, and casters and glides. ... performance in a variety of environments including: ... health care and office. • With tubular ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....
Medicine Products: